No Data
Harrow to Present at Two Investor Conferences in May
NASHVILLE, Tenn.--(BUSINESS WIRE)--$HROW--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor
Harrow Inc (HROW) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Advances
Earnings Call Summary | Harrow(HROW.US) Q1 2024 Earnings Conference
The following is a summary of the Harrow, Inc. (HROW) Q1 2024 Earnings Call Transcript:Financial Performance:Harrow Inc. reported a rise of 33% in revenues for Q1 2024 compared to Q1 2023.Increased it
Harrow Health's Promising Growth Trajectory and Strong Financial Outlook Reinforce Buy Rating
JAN, MTC and PROK Among Mid-day Movers
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Alibaba Group Holding Limited (NYSE:BABA) fell sharply during Tuesday's session following mixed first-quarter financial results.The e-commerce giant reported fiscal fourth-quarter 2023 reven